212 related articles for article (PubMed ID: 10536175)
1. Comprehensive analysis of p53 gene mutation characteristics in lung carcinoma with special reference to histological subtypes.
Fujita T; Kiyama M; Tomizawa Y; Kohno T; Yokota J
Int J Oncol; 1999 Nov; 15(5):927-34. PubMed ID: 10536175
[TBL] [Abstract][Full Text] [Related]
2. p53 gene mutations in non-small cell lung cancer detected by polymerase chain reaction single-strand conformation polymorphism analysis.
Zhao Y; Wu D; Xiang X; Zhang B; Zhou N; Hu Y
Chin Med Sci J; 1999 Sep; 14(3):134-7. PubMed ID: 12903811
[TBL] [Abstract][Full Text] [Related]
3. Comparison of p53 mutations between adenocarcinoma and squamous cell carcinoma of the lung: unique spectra involving G to A transitions and G to T transversions in both histologic types.
Gao WM; Mady HH; Yu GY; Siegfried JM; Luketich JD; Melhem MF; Keohavong P
Lung Cancer; 2003 May; 40(2):141-50. PubMed ID: 12711114
[TBL] [Abstract][Full Text] [Related]
4. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
[TBL] [Abstract][Full Text] [Related]
5. Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer.
Huang CL; Taki T; Adachi M; Konishi T; Higashiyama M; Kinoshita M; Hadama T; Miyake M
Int J Oncol; 1998 Mar; 12(3):553-63. PubMed ID: 9472092
[TBL] [Abstract][Full Text] [Related]
6. Distribution of p53 and K-ras mutations in human lung cancer tissues.
Gao HG; Chen JK; Stewart J; Song B; Rayappa C; Whong WZ; Ong T
Carcinogenesis; 1997 Mar; 18(3):473-8. PubMed ID: 9067544
[TBL] [Abstract][Full Text] [Related]
7. Association between p53 mutation and clinicopathological features of non-small cell lung cancer.
Guang SG; Ogura T; Sekine I; Yokozaki M; Esumi H; Kodama T; Nagai K
Jpn J Clin Oncol; 1997 Aug; 27(4):211-5. PubMed ID: 9379505
[TBL] [Abstract][Full Text] [Related]
8. Clonality analysis of different histological components in combined small cell and non-small cell carcinoma of the lung.
Murase T; Takino H; Shimizu S; Inagaki H; Tateyama H; Takahashi E; Matsuda H; Eimoto T
Hum Pathol; 2003 Nov; 34(11):1178-84. PubMed ID: 14652820
[TBL] [Abstract][Full Text] [Related]
9. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
10. p53 gene aberrations in non-small-cell lung carcinomas from a smoking population.
Liloglou T; Ross H; Prime W; Donnelly RJ; Spandidos DA; Gosney JR; Field JK
Br J Cancer; 1997; 75(8):1119-24. PubMed ID: 9099958
[TBL] [Abstract][Full Text] [Related]
11. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of mutations and a germ line polymorphism of the p53 gene in non-small cell lung carcinoma: association with clinicopathological features.
Tagawa M; Murata M; Kimura H
Cancer Lett; 1998 Jun; 128(1):93-9. PubMed ID: 9652798
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of mutation types of p53 gene and possible carcinogenic factors in lung cancer].
Gao ZQ; Gao Z; Zhang X
Zhonghua Yu Fang Yi Xue Za Zhi; 1997 Mar; 31(2):88-91. PubMed ID: 9812619
[TBL] [Abstract][Full Text] [Related]
14. Gender comparisons in human lung cancer: analysis of p53 mutations, anti-p53 serum antibodies and C-erbB-2 expression.
Guinee DG; Travis WD; Trivers GE; De Benedetti VM; Cawley H; Welsh JA; Bennett WP; Jett J; Colby TV; Tazelaar H
Carcinogenesis; 1995 May; 16(5):993-1002. PubMed ID: 7767998
[TBL] [Abstract][Full Text] [Related]
15. Detection and evaluation of p53 intron 2 polymorphism in lung carcinomas in Hong Kong.
Ge H; Lam WK; Lee J; Wong MP; Fu KH; Yew WW; Lung ML
Int J Cancer; 1996 Apr; 69(2):120-4. PubMed ID: 8608979
[TBL] [Abstract][Full Text] [Related]
16. Gene analysis of K-, H-ras, p53, and retinoblastoma susceptibility genes in human lung cancer cell lines by the polymerase chain reaction/single-strand conformation polymorphism method.
Kashii T; Mizushima Y; Monno S; Nakagawa K; Kobayashi M
J Cancer Res Clin Oncol; 1994; 120(3):143-8. PubMed ID: 8263009
[TBL] [Abstract][Full Text] [Related]
17. Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.
Ludovini V; Pistola L; Gregorc V; Floriani I; Rulli E; Piattoni S; Di Carlo L; Semeraro A; Darwish S; Tofanetti FR; Stocchi L; Mihaylova Z; Bellezza G; Del Sordo R; Daddi G; Crinò L; Tonato M
J Thorac Oncol; 2008 Apr; 3(4):365-73. PubMed ID: 18379354
[TBL] [Abstract][Full Text] [Related]
18. Carcinogen exposure, p53 alteration, and K-ras mutation in synchronous multiple primary lung carcinoma.
Wang X; Christiani DC; Mark EJ; Nelson H; Wiencke JK; Gunn L; Wain JC; Kelsey KT
Cancer; 1999 Apr; 85(8):1734-9. PubMed ID: 10223567
[TBL] [Abstract][Full Text] [Related]
19. Correlation of the mutation of p53 gene and the polymorphism at codon 72 in smoking-related non-small cell lung cancer patients.
Murata M; Tagawa M; Kimura H; Kakisawa K; Shirasawa H; Fujisawa T
Int J Oncol; 1998 Mar; 12(3):577-81. PubMed ID: 9472095
[TBL] [Abstract][Full Text] [Related]
20. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis.
Kawasaki H; Ogura T; Yokose T; Nagai K; Nishiwaki Y; Esumi H
Hum Pathol; 2001 Oct; 32(10):1043-9. PubMed ID: 11679937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]